Literature DB >> 17410578

The H reflex from the abductor brevis hallucis muscle in healthy subjects.

Maurizio Versino1, Elisa Candeloro, Eleonora Tavazzi, Arrigo Moglia, Giorgio Sandrini, Enrico Alfonsi.   

Abstract

In order to evaluate the clinical applicability of a neurophysiological technique, information is required about the effect of technical and subjective factors on the measured parameters, and whether these measures are reliable. The reliability of measurement of a given parameter is inversely related to the variability shown by a set of measurements of that parameter made on the same subject under similar conditions. Reliable measures are fundamental to the clinical utility of any technique. We evaluated the reliability using the intraclass correlation coefficient (ICC), and assessed both single-point and test-retest normal limits for H-reflex parameters of abductor brevis hallucis (ABH). The H reflex from the ABH muscle was recorded in 36 of 43 subjects, but could not be elicited in 7 of 11 subjects who were >60 years of age. The Hmax latency increased as height increased, whereas Hmax amplitude and Hmax/Mmax amplitude ratio decreased as age and height increased. The Hmax latency and Hmax/Mmax amplitude ratio, but not Hmax amplitude, proved to be reliable. The usefulness of the H reflex from ABH in the evaluation of S2 radiculopathies is described.

Entities:  

Mesh:

Year:  2007        PMID: 17410578     DOI: 10.1002/mus.20775

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

Review 1.  Retraining Reflexes: Clinical Translation of Spinal Reflex Operant Conditioning.

Authors:  Amir Eftekhar; James J S Norton; Christine M McDonough; Jonathan R Wolpaw
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

2.  Repeatability of spinal reflexes of lower limb muscles evoked by transcutaneous spinal cord stimulation.

Authors:  Akira Saito; Yohei Masugi; Kento Nakagawa; Hiroki Obata; Kimitaka Nakazawa
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.